Mutation Hot Spot Region in the HOGA1 Gene Associated with Primary Hyperoxaluria Type 3 in the Chinese Population. 2019

Wenying Wang, and Yi Liu, and Lulu Kang, and Ruxuan He, and Jinqing Song, and Yanhan Li, and Jun Li, and Yanling Yang
Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

BACKGROUND Primary hyperoxaluria type 3 (PH3) is a rare autosomal recessive disorder that affects glyoxylate metabolism. PH3 is caused by defects in 4-hydroxy-2-oxoglutarate aldolase, which is encoded by the HOGA1 gene. However, only 3 cases of PH3 have been described in Asians until today. This study aimed to determine the clinical and mutation spectra of patients from mainland China with PH3. METHODS We applied targeted next-generation sequencing to four non-consanguineous, unrelated Chinese families with PH3 to identify the genes hosting disease-causing mutations. This approach was confirmed by Sanger sequencing. RESULTS Five patients (2 boys and 3 girls) from four unrelated Chinese families were admitted because of kidney stones. Five HOGA1 gene sequence mutations were detected, including two novel mutations, c.811C>T (p.R271C) and c.812G>A (p.R271H). These compound heterozygous mutations were detected in a female PH3 patient (patient 4). Other patients included 2 boys who had heterozygous c.834_834+1GG>TT and c.834G>A (p.A278A) mutations (patients 1 and 2), a girl with homozygous c.834G>A (p.A278A) mutation (patient 3), and a girl with heterozygous c.834_834+1GG>TT and c.346C>T (p.Q116X) mutations (patient 5). The mutations in the c.834_834+1 region, including c.834G>A, c.834+1G>T, and c.834_834+1GG>TT, account for 5/8 of alleles in our study and 3/4 of alleles reported among Chinese patients. All patients in this study received hyperhydration and urine alkalinization treatment. CONCLUSIONS Five PH3 cases were reported. Potential mutation hot spot region (c.834_834+1) in the Chinese population and two novel mutations were found.

UI MeSH Term Description Entries
D006960 Hyperoxaluria, Primary A genetic disorder characterized by excretion of large amounts of OXALATES in urine; NEPHROLITHIASIS; NEPHROCALCINOSIS; early onset of RENAL FAILURE; and often a generalized deposit of CALCIUM OXALATE. There are subtypes classified by the enzyme defects in glyoxylate metabolism. Oxaluria, Primary,Primary Hyperoxaluria,Primary Oxalosis,Primary Oxaluria,Hyperoxalurias, Primary,Oxaloses, Primary,Oxalosis, Primary,Oxalurias, Primary,Primary Hyperoxalurias,Primary Oxaloses,Primary Oxalurias
D007652 Oxo-Acid-Lyases Enzymes that catalyze the cleavage of a carbon-carbon bond of a 3-hydroxy acid. (Dorland, 28th ed) EC 4.1.3. Ketoacid-Lyases,Ketoacid Lyases,Oxo Acid Lyases
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017422 Sequence Analysis, DNA A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis. DNA Sequence Analysis,Sequence Determination, DNA,Analysis, DNA Sequence,DNA Sequence Determination,DNA Sequence Determinations,DNA Sequencing,Determination, DNA Sequence,Determinations, DNA Sequence,Sequence Determinations, DNA,Analyses, DNA Sequence,DNA Sequence Analyses,Sequence Analyses, DNA,Sequencing, DNA

Related Publications

Wenying Wang, and Yi Liu, and Lulu Kang, and Ruxuan He, and Jinqing Song, and Yanhan Li, and Jun Li, and Yanling Yang
May 2017, Journal of clinical laboratory analysis,
Wenying Wang, and Yi Liu, and Lulu Kang, and Ruxuan He, and Jinqing Song, and Yanhan Li, and Jun Li, and Yanling Yang
January 2015, American journal of nephrology,
Wenying Wang, and Yi Liu, and Lulu Kang, and Ruxuan He, and Jinqing Song, and Yanhan Li, and Jun Li, and Yanling Yang
December 2018, The Tohoku journal of experimental medicine,
Wenying Wang, and Yi Liu, and Lulu Kang, and Ruxuan He, and Jinqing Song, and Yanhan Li, and Jun Li, and Yanling Yang
October 2019, Pediatric nephrology (Berlin, Germany),
Wenying Wang, and Yi Liu, and Lulu Kang, and Ruxuan He, and Jinqing Song, and Yanhan Li, and Jun Li, and Yanling Yang
April 2021, Molecular biology reports,
Wenying Wang, and Yi Liu, and Lulu Kang, and Ruxuan He, and Jinqing Song, and Yanhan Li, and Jun Li, and Yanling Yang
December 2022, Human mutation,
Wenying Wang, and Yi Liu, and Lulu Kang, and Ruxuan He, and Jinqing Song, and Yanhan Li, and Jun Li, and Yanling Yang
September 2011, Clinical journal of the American Society of Nephrology : CJASN,
Wenying Wang, and Yi Liu, and Lulu Kang, and Ruxuan He, and Jinqing Song, and Yanhan Li, and Jun Li, and Yanling Yang
December 2013, Gene,
Wenying Wang, and Yi Liu, and Lulu Kang, and Ruxuan He, and Jinqing Song, and Yanhan Li, and Jun Li, and Yanling Yang
February 2009, Indian journal of pediatrics,
Wenying Wang, and Yi Liu, and Lulu Kang, and Ruxuan He, and Jinqing Song, and Yanhan Li, and Jun Li, and Yanling Yang
March 2012, The Journal of urology,
Copied contents to your clipboard!